Beckman Coulter to Host Second Annual Investor Conference on March 9 and 12, 2001.Business Editors FULLERTON, Calif.--(BUSINESS WIRE)--Feb. 23, 2001 Beckman Coulter This article needs sources or references that appear in reliable, third-party publications. Alone, primary sources and sources affiliated with the subject of this article are not sufficient for an accurate encyclopedia article. , Inc. (NYSE NYSE See: New York Stock Exchange :BEC) announced today it will host its Second Annual Investor Conference in the form of two luncheon events. The first event is set for Friday, March 9, 2001 at the company's headquarters in Fullerton, California Fullerton is a city located in northern Orange County, California, United States. As of the 2000 census, the city had a total population of 126,003. It was founded in 1887 by George and Edward Amerige and named for George H. , with the option of participating in a two hour company facilities tour; the second on Monday, March 12, 2001 in New York New York, state, United States New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of , New York. The conference will be hosted by Jack Wareham, chairman, president and chief executive officer; and a host of top corporate, clinical diagnostics and life science research executives, who will discuss the company's strategy and share updates on the company's investment in high potential areas. If you would like to attend one of these meetings, please contact Beckman Coulter's Investor Relations Investor relations The process by which the corporation communicates with its investors. department for event details at 714/773-8213 or send an e-mail to: cgskoglund@beckman.com. The conference scheduled for Friday, March 9, 2001 will be webcast live. The conference is accessible to all investors through Beckman Coulter's website at www.beckmancoulter.com. When accessing the webcast through the Beckman Coulter site, select the Investor Relations icon and follow the path to "Live Webcast". The webcast will be archived for future on-demand replay through Monday, March 26, 2001. Beckman Coulter, Inc. is a leading provider of instrument systems and complementary products that simplify and automate processes in life science and clinical laboratories. The company's products are used throughout the world in all phases of the battle against disease, from pioneering medical research and drug discovery to diagnostic testing Diagnostic testing Testing performed to determine if someone is affected with a particular disease. Mentioned in: Von Willebrand Disease that aids in patient treatment. Annual sales for the company totaled $1.89 billion in 2000, with approximately half of this amount generated outside the United States. For more information visit www.beckmancoulter.com. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion